JP Morgan was the leading financial adviser globally for mergers and acquisitions (M&A) in Q1 2019 in the healthcare sector, according to GlobalData.

Despite advising on the same number of deals as JP Morgan, which secured $139.5bn from nine deals, Goldman Sachs trailed at sixth position with a deal value of $48.6bn.

It also topped the GlobalData’s Q1 2019 ranking of top 20 financial advisers for global mergers and acquisitions.

GlobalData has published a top 10 league table of financial advisers ranked according to the value of announced M&A deals globally. If value remains same for multiple advisers, deal volume is given weightage.

Citi secured second spot with deals worth $115.2bn, followed by Evercore Partners with $108.3bn.

Nagarjun Sura, financial deals analyst at GlobalData, said: “The $89.5bn Bristol-Myers’ acquisition of Celgene and the $21.4bn Danaher’s acquisition of BioPharma business of General Electric were instrumental in determining financial advisers’ rankings, as eight of the top 10 advisors advised on either one of these deals. JP Morgan and Citi,the top two financial advisers for the healthcare sector in Q1 2019, were involved in both the deals.”

The healthcare sector witnessed a 21.0% jump in deal value from $151.6bn in Q1 2018 to $183.5bn in Q1 2019, and 27.4% increase in deal volume from 1,017 in Q1 2018 to 1,296 in Q1 2019.

American law firm Kirkland & Ellis stood winner in the top 10 legal advisers list for healthcare sector by value and volume and also in the global league table of top 20 legal advisers for Q1 2019.

The firm advised on 10 deals worth a total of $132.5bn, surpassing its competitors in the healthcare sector. Even though Wachtell Lipton Rosen & Katz provided legal services to only two deals in Q1 2019, it took second spot in the sector table with a total deal value of $95.3bn.

GlobalData’s league tables are based on the real-time tracking of thousands of company websites, advisory firm websites and other reliable sources available on the secondary domain. A dedicated team of analysts monitors all these sources to gather in-depth details for each deal, including adviser names.

To ensure further robustness to the data, the company also seeks submissions from leading advisers, through adviser submission forms on GlobalData’s website